[Secondary focal dystonia].
Deligny
C
C
Service de Neurologie, Hôpital G et R Laënnec, CHU, Nantes, France.
Raoul
S
S
de Ferron
E
E
Auffray
E
E
Guillon
B
B
D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000627:therapeutic use; D003287:Contrast Media; D020821:Dystonic Disorders / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D004569:Electroencephalography; D005682:Gadolinium; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D013116:Spinal Cord / Q000000981:diagnostic imaging / Q000473:pathology*; D014103:Torticollis / Q000150:complications / Q000473:pathology; D014463:Ultrasonography
D018726:Anti-Dyskinesia Agents; D003287:Contrast Media; D005682:Gadolinium; D001905:Botulinum Toxins